Financhill
Back

Bicycle Therapeutics PLC Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
17

BCYC
Bicycle Therapeutics PLC

Last Price:
23.73
Seasonality Move:
18.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Bicycle Therapeutics PLC Price Quote

$23.73
+0.27 (+1.15%)
(Updated: November 5, 2024 at 2:45 PM ET)

Bicycle Therapeutics PLC Key Stats

Sell
17
Bicycle Therapeutics PLC (BCYC) is a Sell

Day range:
$22.54 - $24.50
52-week range:
$12.54 - $28.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
32.75
P/B ratio:
1.95%

Volume:
353K
Avg. volume:
457.4K
1-year change:
51.06%
Market cap:
$1.6B
Revenue:
$27M
EPS:
$-3.29

How Much Does Bicycle Therapeutics PLC Make?

Is Bicycle Therapeutics PLC Growing As A Company?

Bicycle Therapeutics PLC Stock Price Performance

What Is Bicycle Therapeutics PLC 52-Week High & Low?

Bicycle Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bicycle Therapeutics PLC?

Is Bicycle Therapeutics PLC Cash Flow Positive?

  • What Is BCYC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$202.6M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $519.9M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$918K

Bicycle Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    BCYC return on invested capital is -27.99%
  • What Is Bicycle Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -21.68%
  • What Is BCYC Return On Equity?
    ROE is a measure of profitability and is -29.19%

Bicycle Therapeutics PLC Earnings Date & Stock Price

Bicycle Therapeutics PLC Competitors

Bicycle Therapeutics PLC Dividend Yield

Bicycle Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.46%
Revenue: -50% -61.8%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 39.10
Upside from Last Price: 66.67%

Major Shareholders

  • How many BCYC shares are owned by institutional investors?
    55.2M BCYC shares are owned by institutional investors
  • How many BCYC shares are owned by insiders?
    1.1M BCYC shares are owned by insiders